# Assessment of Alcon's Ocular Image Quantification System

> **NCT01282138** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 13 (actual)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** Olopatadine hydrochloride, 0.1% ophthalmic solution (Patanol)
- **OTHER:** Dextran 70 0.1%, hydroxypropyl methylcellulose 0.3% (Tears Naturale II)

## Key facts

- **NCT ID:** NCT01282138
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2012-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01282138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01282138, "Assessment of Alcon's Ocular Image Quantification System". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01282138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*